Predictive factors of radiographic progression in ankylosing spondylitis
暂无分享,去创建一个
E. Koh | H. Cha | J. Ahn | Jaejoon Lee | Jiwon Hwang | Eun-Jung Park | Hyungjin Kim | H. Jeong
[1] A. Boonen,et al. Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. , 2010, Rheumatology.
[2] S. Ozgoçmen,et al. Acute-phase response, clinical measures and disease activity in ankylosing spondylitis. , 2007, Joint, bone, spine : revue du rhumatisme.
[3] J. Braun,et al. Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes , 2007, Annals of the rheumatic diseases.
[4] F. Luyten,et al. Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. , 2007, Arthritis and rheumatism.
[5] H. Stein,et al. Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: evaluation of the bone-cartilage interface and subchondral bone marrow. , 2006, Arthritis and rheumatism.
[6] J. Braun,et al. Assessments in ankylosing spondylitis. , 2006, Best practice & research. Clinical rheumatology.
[7] S. van der Linden,et al. How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured? , 2005, Arthritis and rheumatism.
[8] M. Dougados,et al. Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. , 2005, Rheumatology.
[9] B. Dijkmans,et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). , 2005, Arthritis and rheumatism.
[10] B Combe,et al. How to predict prognosis in early rheumatoid arthritis. , 2005, Best practice & research. Clinical rheumatology.
[11] M. A. van 't Hof,et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system , 2004, Annals of the rheumatic diseases.
[12] C. D. Yoo,et al. Clinical features of adult-onset ankylosing spondylitis in Korean patients: patients with peripheral joint disease (PJD) have less severe spinal disease course than those without PJD. , 2004, Rheumatology.
[13] M. Dougados,et al. What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. , 2004, Arthritis and rheumatism.
[14] M. Dougados,et al. The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. , 2004, Arthritis & Rheumatism.
[15] W. Ollier,et al. Polymyalgia rheumatica and biopsy-proven giant cell arteritis exhibit different HLA-DRB1* associations. , 2003, The Journal of rheumatology.
[16] M. Dougados,et al. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. , 2003, Arthritis and rheumatism.
[17] E. Collantes-Estévez,et al. Biological and clinical markers of disease activity in ankylosing spondylitis. , 2003, The Journal of rheumatology.
[18] Sinead Brophy,et al. The natural history of ankylosing spondylitis as defined by radiological progression. , 2002, The Journal of rheumatology.
[19] G. Stucki,et al. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. , 1999, The Journal of rheumatology.
[20] M. Dougados,et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. , 1999, The Journal of rheumatology.
[21] F. caligaris-Cappio,et al. ANEMIA OF CHRONIC DISORDERS IN SYSTEMIC AUTOIMMUNE DISEASES , 2022 .
[22] W. Fraser,et al. Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity. , 1997, British journal of rheumatology.
[23] K. Federlin,et al. Evidence of impaired cartilage/bone turnover in patients with active ankylosing spondylitis. , 1995, Annals of the rheumatic diseases.
[24] M. Dougados,et al. Predictive factors for the longterm outcome of spondyloarthropathies. , 1994, The Journal of rheumatology.
[25] H. Bird,et al. Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis. , 1994, British journal of rheumatology.
[26] S. Krantz,et al. Progress in understanding the pathogenesis of the anemia of chronic disease. , 1992, Blood.
[27] G. Birgegard,et al. Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin. , 1992, Annals of the rheumatic diseases.
[28] E.,et al. Progress in Understanding the Pathogenesis of the Anemia of Chronic Disease , 1992 .
[29] P. Dawes,et al. The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis. , 1991, British journal of rheumatology.
[30] J. Mathews,et al. Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis. , 1986, British journal of rheumatology.
[31] J. Rubenstein,et al. The natural disease course of ankylosing spondylitis. , 1983, Arthritis and rheumatism.
[32] E. L. Persons,et al. Ankylosing Spondylitis , 1955, GP.